chr5-141331372-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_018912.3(PCDHGA1):āc.688A>Gā(p.Ile230Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,614,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_018912.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDHGA1 | NM_018912.3 | c.688A>G | p.Ile230Val | missense_variant | 1/4 | ENST00000517417.3 | NP_061735.1 | |
PCDHGA1 | NM_031993.2 | c.688A>G | p.Ile230Val | missense_variant | 1/1 | NP_114382.1 | ||
PCDHG@ | use as main transcript | n.141331372A>G | intragenic_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDHGA1 | ENST00000517417.3 | c.688A>G | p.Ile230Val | missense_variant | 1/4 | 1 | NM_018912.3 | ENSP00000431083.1 | ||
PCDHGA1 | ENST00000378105.4 | c.688A>G | p.Ile230Val | missense_variant | 1/1 | 6 | ENSP00000367345.3 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000286 AC: 72AN: 251366Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135864
GnomAD4 exome AF: 0.000412 AC: 603AN: 1461878Hom.: 0 Cov.: 37 AF XY: 0.000386 AC XY: 281AN XY: 727244
GnomAD4 genome AF: 0.000401 AC: 61AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 14, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at